Literature DB >> 10790285

Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields.

G A Boorman1, C N Rafferty, J M Ward, R C Sills.   

Abstract

A weak association between residential or occupational exposure to electric and magnetic fields (50/60 Hz fields) and an increased incidence of leukemia has been reported. Numerous animal studies have evaluated the potential association between magnetic-field exposure and leukemia. These include long-term (up to 2(1/2) years) bioassays, initiation/promotion studies, investigations in transgenic models, and tumor growth studies. Exposure to 60 Hz circularly polarized magnetic fields at 1,400 microT for 28 months did not affect lymphoma incidence in mice. The study included over 2000 C57BL/6J mice. In another study, 1000 B6C3F(1) mice exposed to 60 Hz magnetic fields up to 1000 microT for 2 years showed no increase in lymphomas. Approximately 400 transgenic Emu-Pim1 mice exposed to 50 Hz fields up to 1000 microT for up to 18 months had no increased incidence of leukemia. Similarly, Trp53(+/-) mice and Pim1transgenic mice exposed to 60 Hz magnetic fields for 23 weeks showed no increased incidence of lymphoma. Three studies in F344 rats exposed to 50 or 60 Hz magnetic fields up to 5 mT showed no increased incidence of leukemia. The combined animal bioassay results are nearly uniformly negative for magnetic-field exposures enhancing leukemia and weaken the possible epidemiological association between magnetic-field exposures and leukemia in humans as suggested by epidemiological data.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790285     DOI: 10.1667/0033-7587(2000)153[0627:laliir]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Exposure to electrical contact currents and the risk of childhood leukemia.

Authors:  Monique Does; Ghislaine Scélo; Catherine Metayer; Steve Selvin; Robert Kavet; Patricia Buffler
Journal:  Radiat Res       Date:  2010-12-08       Impact factor: 2.841

Review 2.  The Impact of the Low Frequency of the Electromagnetic Field on Human.

Authors:  Kawthar A Diab
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.

Authors:  Olivier Negre; Cynthia Bartholomae; Yves Beuzard; Marina Cavazzana; Lauryn Christiansen; Céline Courne; Annette Deichmann; Maria Denaro; Edouard de Dreuzy; Mitchell Finer; Raffaele Fronza; Béatrix Gillet-Legrand; Christophe Joubert; Robert Kutner; Philippe Leboulch; Leïla Maouche; Anaïs Paulard; Francis J Pierciey; Michael Rothe; Byoung Ryu; Manfred Schmidt; Christof von Kalle; Emmanuel Payen; Gabor Veres
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

Review 4.  Childhood leukemia: electric and magnetic fields as possible risk factors.

Authors:  Joseph D Brain; Robert Kavet; David L McCormick; Charles Poole; Lewis B Silverman; Thomas J Smith; Peter A Valberg; R A Van Etten; James C Weaver
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

5.  Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγnull (NOG) mice.

Authors:  Masahiko Yasuda; Tomoyuki Ogura; Takayuki Goto; Mika Yagoto; Yoko Kamai; Chie Shimomura; Nobuhito Hayashimoto; Yukito Kiyokawa; Hideki Shinohara; Riichi Takahashi; Kenji Kawai
Journal:  Exp Anim       Date:  2017-07-06

6.  Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy.

Authors:  Raisa Jofra Hernández; Andrea Calabria; Francesca Sanvito; Fabiola De Mattia; Giada Farinelli; Serena Scala; Ilaria Visigalli; Nicola Carriglio; Maura De Simone; Michela Vezzoli; Francesca Cecere; Maddalena Migliavacca; Luca Basso-Ricci; Maryam Omrani; Fabrizio Benedicenti; Rossana Norata; Paola Maria Vittoria Rancoita; Clelia Di Serio; Paola Albertini; Patrizia Cristofori; Luigi Naldini; Bernhard Gentner; Eugenio Montini; Alessandro Aiuti; Alessandra Mortellaro
Journal:  Mol Ther       Date:  2020-09-23       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.